...
首页> 外文期刊>Acta Poloniae Pharmaceutica: Durg Research >Mechanism of solvolysis of N-(2-(4-o-fluorophenylpiperazin-1-yl)ethyl)-2,5-dimethyl-1-phenylpyrrole-3,4-dica rboximide (PDI).
【24h】

Mechanism of solvolysis of N-(2-(4-o-fluorophenylpiperazin-1-yl)ethyl)-2,5-dimethyl-1-phenylpyrrole-3,4-dica rboximide (PDI).

机译:N-(2-(4-(4-o-氟苯基哌嗪-1-基)乙基)-2,5-二甲基-1-苯基吡咯-3,4-二氧萘酰亚胺(PDI)的溶剂分解机理。

获取原文
获取原文并翻译 | 示例
           

摘要

The stability of N-[2-(4-o-fluorophenylpiperazin-1-yl)ethyl]-2,5-dimethyl-1-phenylpyrrole-3,4-dica rboximide (PDI; a derivative with an analgesic activity) was studied in order to investigate its degradation mechanism and identify its degradation products in aqueous-organic solutions. The stability of PDI and its two degradation products (A and B) was performed with an HPLC method: (LiChrospher C18 column (250 x 4 mm LD., dp = 5 microm), mobile phase: 3.5 g/L solution of sodium lauryl sulfate and 1.6 mL of phosphoric acid(V)-acetonitrile (40:60, v/v), UV detector: 240 nm, flow rate: 1 ml/min). The identification of products A and B was conducted using HPLC-ES-MS and 1H- and 13C-NMR methods.
机译:研究了N- [2-(4-(-o-氟苯基哌嗪-1-基)乙基] -2,5-二甲基-1-苯基吡咯-3,4-dica rboximide(PDI;具有镇痛活性的衍生物)的稳定性为了研究其降解机理并鉴定其在有机水溶液中的降解产物。 PDI及其两个降解产物(A和B)的稳定性通过HPLC方法进行:(Li​​Chrospher C18色谱柱(250 x 4 mm LD。,dp = 5 microm),流动相:3.5 g / L月桂基钠溶液硫酸盐和1.6 mL磷酸(V)-乙腈(40:60,v / v),UV检测器:240 nm,流速:1 ml / min)。使用HPLC-ES-MS以及1H-和13C-NMR方法对产物A和B进行鉴定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号